You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphoma, Mantle-Cell

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Resectable Esophageal Squamous Cell Carcinoma Trial in Shanghai (SHR-1210)

Not yet recruiting
  • Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Sep 5, 2021

Lymphoproliferative Disorder, HHV-8, Malignancy Trial run by the National Cancer Institute (NCI) (Etoposide, Interferon-alpha,

Active, not recruiting
  • Lymphoproliferative Disorder
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Multiple Myeloma Trial in Hackensack (Pembrolizumab, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Hackensack, New Jersey
    John Theurer Cancer Center-Hackensack Meridian Health
Jan 18, 2022

Retinitis Pigmentosa Trial in Spain, United Kingdom, United States (hRPC)

Active, not recruiting
  • Retinitis Pigmentosa
  • Phoenix, Arizona
  • +4 more
Jan 19, 2022

Wheatgrass and Tulsi Formulation or Individuals Taken With Other

Not yet recruiting
  • Blood Pressure, High
  • +3 more
  • Observation study
  • Pune, Maharashtra, India
    Sinhgad college of Pharmacy
May 5, 2023

Malignant Epithelial Tumors Trial in Portland (TCR-transduced T cells, CDX-1140, Pembrolizumab)

Not yet recruiting
  • Malignant Epithelial Neoplasms
  • TCR-transduced T cells
  • +2 more
  • Portland, Oregon
    Providence Portland Medical Center
Apr 22, 2022

Genetic Basis of Primary Immunodeficiencies

Terminated
  • Immunologic Deficiency Syndrome
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    May 26, 2021

    NSCLC Trial (disease self-management application)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • disease self-management application
    • (no location specified)
    Nov 9, 2022

    Crosstalk Between Mucosal-Associated Invariant T Cells and Gut

    Recruiting
    • Type1diabetes
    • MAIT cells analysis
    • +4 more
    • Antony, France
    • +1 more
    Aug 2, 2022

    Split Thickness Skin Graft, Wound Healing Trial in Nantes (biological dressing, Paraffin gauze dressing)

    Recruiting
    • Split Thickness Skin Graft
    • Wound Healing
    • biological dressing
    • Paraffin gauze dressing
    • Nantes, France
    • +1 more
    Apr 4, 2022

    Idiopathic Pulmonary Fibrosis, Acute Fatal Form Trial in United States (Autoantibody Reductive Therapy, Treatment as Usual

    Recruiting
    • Idiopathic Pulmonary Fibrosis, Acute Fatal Form
    • Autoantibody Reductive Therapy
    • Treatment as Usual (TAU)
    • Birmingham, Alabama
    • +6 more
    Sep 5, 2022

    Metastatic Clear Cell Renal Cell Carcinoma Trial in Dallas (IL-2, Stereotactic Ablative Body Radiation Therapy)

    Completed
    Has Results
    • Metastatic Clear Cell Renal Cell Carcinoma
    • IL-2
    • Stereotactic Ablative Body Radiation Therapy
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Jul 28, 2021

    Prostate Cancer Trial in Québec (Pembrolizumab)

    Recruiting
    • Prostate Cancer
    • Québec, Canada
      CHU de Québec-Université Laval
    Mar 8, 2022

    Stem Cells in NF1 Tumors of the Central Nervous System

    Suspended
    • Neurofibromatosis Type 1
    • Tumors of the Central Nervous System
    • Collection of Stem Cells
    • Washington, District of Columbia
      Children's National Medical Center
    Mar 8, 2022

    Oncology, Neuroendocrine Carcinoma Trial in United Kingdom (Liposomal Irinotecan, Fluorouracil, Folinic Acid)

    Active, not recruiting
    • Oncology
    • Neuroendocrine Carcinoma
    • Liposomal Irinotecan
    • +3 more
    • Glasgow, United Kingdom
    • +3 more
    Dec 2, 2022

    Incomplete HCT (Hematopoietic Cell Transplantation) Trial in Israel, United States (PLX-R18)

    Completed
    • Incomplete HCT (Hematopoietic Cell Transplantation)
    • PLX-R18
    • Chicago, Illinois
    • +9 more
    Dec 15, 2022

    Multiple Myeloma Trial in Boston (CIML NK Cells plus KP1237 and low dose IL-2)

    Recruiting
    • Multiple Myeloma
    • CIML NK Cells plus KP1237 and low dose IL-2
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jan 18, 2022

    Renal Cell Carcinoma Trial in Rome (donor FMT, Placebo FMT)

    Recruiting
    • Renal Cell Carcinoma
    • donor FMT
    • Placebo FMT
    • Rome, Italy
    • +1 more
    Jul 26, 2022

    Acute Myeloid Leukemia Trial in Lanzhou (Venetoclax, Azacitidine, Cladribine)

    Recruiting
    • Acute Myeloid Leukemia
    • Lanzhou, Gansu, China
      Long Zhao
    Apr 24, 2022

    Acute GVHD Trial in United States (natalizumab, steroids)

    Active, not recruiting
    • Acute Graft Versus Host Disease
    • Duarte, California
    • +11 more
    Oct 15, 2021

    Platelet Disorder Trial (Avatrombopag)

    Withdrawn
    • Platelet Disorder
    • (no location specified)
    Nov 26, 2021

    Single-port Video-assisted Thoracoscopic Surgery Trial in Jinan (uniport video-assisted thoracoscopic surgery, two ports

    Recruiting
    • Single-port Video-assisted Thoracoscopic Surgery
    • uniport video-assisted thoracoscopic surgery
    • +2 more
    • Jinan, Shandong, China
      The Second Hospital of Shandong University
    Nov 14, 2022

    Renal Cell Carcinoma, Breast Cancer, Colon Cancer Trial in Bethesda, Hershey, Pittsburgh (DMS 612)

    Completed
    • Renal Cell Carcinoma
    • +4 more
    • DMS 612
    • Bethesda, Maryland
    • +2 more
    Dec 4, 2018

    NSCLC Trial in Amsterdam, Groningen, Maastricht (Afatinib, Cetuximab)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Amsterdam, North-Holland, Netherlands
    • +3 more
    Oct 19, 2021

    Mastocytosis Trial in Toulouse (Hydroxychloroquine)

    Not yet recruiting
    • Mastocytosis
    • Toulouse, France
      Larrey Hospital - Toulouse University Hospital
    Oct 6, 2021